Medicine and Dentistry
Inflammatory Bowel Disease
100%
Crohn's Disease
74%
Patient
67%
Ulcerative Colitis
41%
Association
36%
Inpatient
33%
Combination Therapy
27%
Infliximab
22%
Genome Wide Association Study
21%
Therapeutic Procedure
21%
Patient with Inflammatory Bowel Disease
20%
Adalimumab
19%
Mercaptopurine
19%
Meta-Analysis
18%
Faecal Calprotectin
17%
Spontaneous Remission
16%
Tumor Necrosis Factor
14%
Analysis
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Follow up
13%
COVID-19
12%
Systematic Review
12%
Tumor Necrosis Factor
12%
Disease
12%
Hazard Ratio
11%
Age
11%
Vedolizumab
10%
Observational Study
9%
Phenotype
9%
Patient with Crohn's Disease
8%
Diagnosis
8%
Antibody Response
8%
Gene Expression
8%
Pathogenesis
8%
Vaccine
7%
Adult
7%
Relapse
7%
Biological Product
7%
Prevalence
7%
Immunosuppressive Drug
7%
Complication
6%
Azathioprine
6%
Disease Course
6%
Disease Predisposition
6%
Biopsy
6%
C Reactive Protein
6%
Drug
6%
Chemotherapeutic Agent
6%
Protein
6%
Cohort Analysis
5%
Biochemistry, Genetics and Molecular Biology
Association
51%
Genome-Wide Association Study
30%
Nested Gene
29%
Single Nucleotide Polymorphism
17%
Protein
12%
Genetics
11%
Autophagy
11%
Genetic Architecture
10%
IRGM
10%
Candidate Gene
10%
Sample
9%
Sequencing
8%
Development
8%
Hedgehog Signaling Pathway
8%
Allele
7%
Single-Nucleotide Polymorphism
7%
Phenotype
7%
NOD2
6%
Regulatory Mechanism
6%
Genotyping
5%
Gastrointestinal Tract
5%
Homeostasis
5%
Comprehension
5%
DNA
5%
Genetic Association Study
5%
CARD9
5%
ATG16L1
5%
Immunology and Microbiology
Inflammatory Bowel Disease
47%
Crohn's Disease
37%
Adalimumab
24%
Infliximab
22%
Ulcerative Colitis
18%
Immunogenicity
11%
Biological Product
10%
Association
10%
Antibody Response
9%
Vaccine Efficacy
8%
Genome-Wide Association Study
8%
Development
8%
HLA DQA1 Antigen
8%
Tumor Necrosis Factor Alpha
7%
Gene
7%
Allele
7%
Phenotype
6%
Immunity
6%
Integrin
5%
Dose
5%
Genetic Association Study
5%
